Literature DB >> 34407634

Deletion of AT1a (Angiotensin II Type 1a) Receptor or Inhibition of Angiotensinogen Synthesis Attenuates Thoracic Aortopathies in Fibrillin1C1041G/+ Mice.

Jeff Z Chen1,2,3, Hisashi Sawada1,2,3, Dien Ye1,2, Yuriko Katsumata4,5, Masayoshi Kukida1,2, Satoko Ohno-Urabe1,2, Jessica J Moorleghen1,2, Michael K Franklin1,2, Deborah A Howatt1,2, Mary B Sheppard1,2,3,6,7, Adam E Mullick8, Hong S Lu1,2,3, Alan Daugherty1,2,3.   

Abstract

Objective: A cardinal feature of Marfan syndrome is thoracic aortic aneurysm. The contribution of the renin-angiotensin system via AT1aR (Ang II [angiotensin II] receptor type 1a) to thoracic aortic aneurysm progression remains controversial because the beneficial effects of angiotensin receptor blockers have been ascribed to off-target effects. This study used genetic and pharmacological modes of attenuating angiotensin receptor and ligand, respectively, to determine their roles on thoracic aortic aneurysm in mice with fibrillin-1 haploinsufficiency (Fbn1C1041G/+). Approach and
Results: Thoracic aortic aneurysm in Fbn1C1041G/+ mice was found to be strikingly sexual dimorphic. Males displayed aortic dilation over 12 months while aortic dilation in Fbn1C1041G/+ females did not differ significantly from wild-type mice. To determine the role of AT1aR, Fbn1C1041G/+ mice that were either +/+ or -/- for AT1aR were generated. AT1aR deletion reduced expansion of ascending aorta and aortic root diameter from 1 to 12 months of age in males. Medial thickening and elastin fragmentation were attenuated. An antisense oligonucleotide against angiotensinogen was administered to male Fbn1C1041G/+ mice to determine the effects of Ang II depletion. Antisense oligonucleotide against angiotensinogen administration attenuated dilation of the ascending aorta and aortic root and reduced extracellular remodeling. Aortic transcriptome analyses identified potential targets by which inhibition of the renin-angiotensin system reduced aortic dilation in Fbn1C1041G/+ mice. Conclusions: Deletion of AT1aR or inhibition of Ang II production exerted similar effects in attenuating pathologies in the proximal thoracic aorta of male Fbn1C1041G/+ mice. Inhibition of the renin-angiotensin system attenuated dysregulation of genes within the aorta related to pathology of Fbn1C1041G/+ mice.

Entities:  

Keywords:  Marfan syndrome; angiotensin II; angiotensinogen; aortic aneurysm; renin-angiotensin system

Mesh:

Substances:

Year:  2021        PMID: 34407634      PMCID: PMC8458261          DOI: 10.1161/ATVBAHA.121.315715

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   10.514


  40 in total

Review 1.  Treatment of aortic disease in patients with Marfan syndrome.

Authors:  Dianna M Milewicz; Harry C Dietz; D Craig Miller
Journal:  Circulation       Date:  2005-03-22       Impact factor: 29.690

2.  Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome.

Authors:  Ami B Bhatt; J Stewart Buck; Jonah P Zuflacht; Jessica Milian; Samoneh Kadivar; Kimberlee Gauvreau; Michael N Singh; Mark A Creager
Journal:  Vasc Med       Date:  2015-03-20       Impact factor: 3.239

3.  Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis.

Authors:  Elena M Gallo; David C Loch; Jennifer P Habashi; Juan F Calderon; Yichun Chen; Djahida Bedja; Christel van Erp; Elizabeth E Gerber; Sarah J Parker; Kimberly Sauls; Daniel P Judge; Sara K Cooke; Mark E Lindsay; Rosanne Rouf; Loretha Myers; Colette M ap Rhys; Kathleen C Kent; Russell A Norris; David L Huso; Harry C Dietz
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

4.  Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection.

Authors:  Frank S Cikach; Christopher D Koch; Timothy J Mead; Josephine Galatioto; Belinda B Willard; Kelly B Emerton; Matthew J Eagleton; Eugene H Blackstone; Francesco Ramirez; Eric E Roselli; Suneel S Apte
Journal:  JCI Insight       Date:  2018-03-08

5.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Authors:  Daniel P Judge; Nancy J Biery; Douglas R Keene; Jessica Geubtner; Loretha Myers; David L Huso; Lynn Y Sakai; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

6.  Aortic remodeling after transverse aortic constriction in mice is attenuated with AT1 receptor blockade.

Authors:  Shao-Qing Kuang; Liang Geng; Siddharth K Prakash; Jiu-Mei Cao; Steven Guo; Carlos Villamizar; Callie S Kwartler; Andrew M Peters; Allan R Brasier; Dianna M Milewicz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-18       Impact factor: 8.311

7.  Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.

Authors:  Jennifer P Habashi; Jefferson J Doyle; Tammy M Holm; Hamza Aziz; Florian Schoenhoff; Djahida Bedja; YiChun Chen; Alexandra N Modiri; Daniel P Judge; Harry C Dietz
Journal:  Science       Date:  2011-04-15       Impact factor: 47.728

8.  Sex, pregnancy and aortic disease in Marfan syndrome.

Authors:  Marjolijn Renard; Laura Muiño-Mosquera; Elise C Manalo; Sara Tufa; Eric J Carlson; Douglas R Keene; Julie De Backer; Lynn Y Sakai
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

9.  Heterogeneity of Aortic Smooth Muscle Cells: A Determinant for Regional Characteristics of Thoracic Aortic Aneurysms?

Authors:  Hisashi Sawada; Jeff Z Chen; Bradley C Wright; Mary B Sheppard; Hong S Lu; Alan Daugherty
Journal:  J Transl Int Med       Date:  2018-10-09

10.  Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.

Authors:  Stijntje Hibender; Romy Franken; Cindy van Roomen; Anique Ter Braake; Ingeborg van der Made; Edith E Schermer; Quinn Gunst; Maurice J van den Hoff; Esther Lutgens; Yigal M Pinto; Maarten Groenink; Aeilko H Zwinderman; Barbara J M Mulder; Carlie J M de Vries; Vivian de Waard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-06-09       Impact factor: 8.311

View more
  4 in total

1.  Embryologic Origin Influences Smooth Muscle Cell Phenotypic Modulation Signatures in Murine Marfan Syndrome Aortic Aneurysm.

Authors:  Albert J Pedroza; Alex R Dalal; Rohan Shad; Nobu Yokoyama; Ken Nakamura; Paul Cheng; Robert C Wirka; Olivia Mitchel; Michael Baiocchi; William Hiesinger; Thomas Quertermous; Michael P Fischbein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-07-07       Impact factor: 10.514

2.  Inhibition of the Renin-Angiotensin System Fails to Suppress β-Aminopropionitrile-Induced Thoracic Aortopathy in Mice-Brief Report.

Authors:  Hisashi Sawada; Satoko Ohno-Urabe; Dien Ye; Michael K Franklin; Jessica J Moorleghen; Deborah A Howatt; Adam E Mullick; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-08-25       Impact factor: 10.514

3.  Distinct Contribution of Global and Regional Angiotensin II Type 1a Receptor Inactivation to Amelioration of Aortopathy in Tgfbr1 M318R/+ Mice.

Authors:  Emily E Bramel; Rustam Bagirzadeh; Muzna Saqib; Tyler J Creamer; Wendy A Espinoza Camejo; LaToya Ann Roker; Jennifer Pardo Habashi; Harry C Dietz; Elena Gallo MacFarlane
Journal:  Front Cardiovasc Med       Date:  2022-06-22

Review 4.  Pathophysiology and Therapeutics of Thoracic Aortic Aneurysm in Marfan Syndrome.

Authors:  Keiichi Asano; Anna Cantalupo; Lauriane Sedes; Francesco Ramirez
Journal:  Biomolecules       Date:  2022-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.